Skip to main content
. 2017 Feb 3;2017(2):CD008312. doi: 10.1002/14651858.CD008312.pub3

NCT02015806.

Trial name or title Robust Evaluation to Measure Improvements in Nonadherence from Low‐cost Devices (REMIND)
Methods A parallel‐groups, open‐label, randomised trial
Participants Individuals age 18 ‐ 64 years of both gender have 1 ‐ 3 oral maintenance medication for chronic disease (including epilepsy) in the 12‐month period prior to study eligibility evaluation.
Interventions The RxTimerCap (a pill bottle cap with a digital timer that shows the time elapsed since the medication was last taken ), the Take‐N‐Slide (a patented strip with toggles for each day of the week which are meant to be slid after taking a medication),and the standard pillbox (a plastic organisation box with 1 compartment for every day of the week).
Outcomes Primary outcome measures: optimal medication adherence to all cardiovascular or non‐depression chronic disease medication
Starting date March 2014
Contact information Niteesh K. Choudhry, MD, PhD, Brigham and Women's Hospital, USA
Notes